Clinical Trial Update: Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial update on grazoprevir/elbasvir for genotype 1b chronic hepatitis C after liver or kidney transplantation; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Kidney Transplant Infection
• Liver Transplant Infection

Drugs mentioned

• Grazoprevir/Elbasvir

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Chronic Hepatitis c, Liver Transplant Infection | Phase 4 | Status: TERMINATED